Although small-molecule CCR4 antagonists have been studied in other diseases involving CCR4+ Th2 cells and regulatory T cells, their effects in CTCL have not been previously explored. The gene discussed is CCR4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.